Mylan NL Stock Price, News & Analysis

MYL NASDAQ

Company Description

Mylan NL (NASDAQ: MYL) is a publicly traded pharmaceuticals: generic company in the Health Technology sector.

MYL stock has declined 8.0% over the past year.

This page provides a comprehensive overview of MYL stock, including real-time price data, latest news, SEC filings, insider trading activity, financial highlights, upcoming events, and short interest trends.

Stock Performance

Chart

$—

0.00%

0.00

Last updated:

-7.98%

Performance 1 year

$0.0

Market Cap

541.5M

Shares outstanding

Mylan NL (MYL) stock. Over the past 12 months, the stock has lost 8.0%.

Latest News

View All

November 6, 2020

-3.24%

Mylan Announces Third Quarter 2020 Financial Results and Looks Ahead to the Launch of Viatris Inc.

earnings

November 2, 2020

+4.13%

Mylan Announces Appointment of Experienced Pharmaceutical Executive Bill Szablewski as Head of Capital Markets for Viatris

management

September 15, 2020

+1.14%

Mylan and Development Partner, Synthon, Win Significant European Patent Office Ruling Related to Copaxone® 40mg/mL

September 9, 2020

-2.46%

Mylan to Present at the Morgan Stanley Virtual 18th Annual Global Healthcare Conference

conferences

September 9, 2020

-2.46%

Mylan to Present at the BofA Securities Virtual Global Healthcare Conference

conferences

September 8, 2020

-1.11%

Mylan to Acquire Aspen's Thrombosis Business in Europe

acquisition

Mylan NL has 10 recent news articles. Of the recent coverage, 5 articles coincided with positive price movement and 5 with negative movement. Key topics include earnings, management, conferences, acquisition, partnership. View all MYL news →

SEC Filings

View All

No SEC filings available for MYL.

Financial Highlights

View Full Financials

—

Revenue (TTM)

—

Net Income (TTM)

—

Diluted EPS (TTM)

—

Operating Cash Flow

—

Net Profit Margin

—

Oper. Profit Margin

Upcoming Events

Short Interest History

Last 12 Months

Days to Cover History

Last 12 Months

MYL Company Profile & Sector Positioning

Mylan NL (MYL) operates in the Pharmaceuticals: Generic industry within the broader Health Technology sector and is listed on the NASDAQ.